NCT03268590View on ClinicalTrials.gov

Neuroimaging During Pure Oxygen Breathing

PHASE4CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

October 2, 2017

Primary Completion Date

May 2, 2018

Study Completion Date

May 9, 2018

Conditions
HyperoxiaHypoxia, BrainNeurobehavioral Manifestations
Interventions
DRUG

Oxygen

Persons will undergo MRI, EEG, and complete computerized cognitive testing in baseline room air. Persons will then breathe 100% pure oxygen and undergo MRI, EEG, and complete computerized cognitive testing. Persons will serve as their own controls.

Trial Locations (1)

44106

Case Western Reserve University, Cleveland

All Listed Sponsors
lead

Case Western Reserve University

OTHER

NCT03268590 - Neuroimaging During Pure Oxygen Breathing | Biotech Hunter | Biotech Hunter